Vancomycin Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Vancomycin Hydrochloride Injection (injection) from Hospira, Inc., A Pfizer Company with status No longer listed by FDA. The shortage was first posted on Sep 9, 2025.
Shortage details
- Status
- No longer listed by FDA
- Company
- Hospira, Inc., A Pfizer Company
- Package NDC
- 0409-6531-01
- Dosage Form
- Injection
- Presentation
- Vancomycin Hydrochloride, Injection, 750 mg Single Dose ADD-Vantage® Glass Vial (NDC 0409-6531-01)
- Initial Posting
- Sep 9, 2025